首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy
【2h】

Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy

机译:有或没有细胞的多药耐药性起源 多药耐药基因:催化染色体重排 通过非整倍性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer cells and aneuploid cell lines can acquire resistance against multiple unrelated chemotherapeutic drugs that are over 3,000-fold those of normal levels and display spontaneous resistances up to 20-fold of normal levels. Two different mechanisms were proposed for this phenotype: (i) classical mutation of drug metabolizing genes or (ii) chromosome reassortments, catalyzed by cancer- and cell line-specific aneuploidy, which generate, via new gene dosage combinations, a plethora of cancer phenotypes, including drug resistance. To distinguish between these mechanisms, we have asked whether three mouse cell lines can become drug resistant, from which two or three genes have been deleted, and on which multidrug resistance is thought to depend: Mdr1a, Mdr1b, and Mrp1. Because all three lines could acquire multidrug resistance and were aneuploid, whereas diploid mouse cells could not, we conclude that aneuploid cells become drug resistant via specific chromosome assortments, independent of putative resistance genes. We have asked further whether aneuploid drug-resistant Chinese hamster cells revert spontaneously to drug sensitivity in the absence of cytotoxic drugs at the high rates that are typical of chromosome reassortments catalyzed by aneuploidy or at the very low or zero rates (i.e., deletion) of gene mutation. We found that four drug-resistant hamster cell lines reverted to drug sensitivity at rates of about 2–3% per generation, whereas two closely related lines remained resistant under our conditions. Thus, the karyotypic instability generated by aneuploidy emerges as the common source of the various levels of drug resistance of cancer cells: minor spontaneous resistances reflect accidental chromosome assortments, the high selected resistances reflect complex specific assortments, and multidrug resistance reflects new combinations of unselected genes located on the same chromosomes as selected genes.
机译:癌细胞和非整倍体细胞系可以获得对多种不相关化学疗法药物的抗性,这些抗药性是正常水平的3000倍以上,并表现出自发耐药性,最高可达正常水平的20倍。对于这种表型,提出了两种不同的机制:(i)药物代谢基因的经典突变或(ii)由癌症和细胞系特异性非整倍性催化的染色体重排,其通过新的基因剂量组合产生大量的癌症表型。 ,包括耐药性。为了区分这些机制,我们询问了三种小鼠细胞系是否可以变成耐药性,其中两个或三个基因已被删除,并且据信多药耐药性依赖于它们:Mdr1a,Mdr1b和Mrp1。因为所有三个品系都能获得多药耐药性,并且都是非整倍体,而二倍体小鼠细胞却不能,因此我们得出结论,非整倍体细胞通过特定的染色体分类而成为耐药性,而与推定的耐药基因无关。我们进一步询问了是否非整倍体 耐药的中国仓鼠细胞自发转化为药物 在没有细胞毒性药物的情况下的高敏感性 是非整倍性或在 基因突变的发生率非常低或为零(即删除)。我们找到 四个耐药的仓鼠细胞系恢复为药物 每代的敏感度约为2-3%,而两个 在我们的条件下,密切相关的品系仍然可以抵抗。从而, 非整倍性产生的核型不稳定性随着 癌细胞各种级别的耐药性的共同来源: 较小的自发抵抗力反映偶然的染色体 品种,高选择的电阻反映了复杂的比 种类和耐多药性反映了 与选定基因位于同一染色体上的未选定基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号